Remote Controlled 3D Printed Pills to Inhibit Cancer Growth

IMTS

Share this Article

Central to the treatment of most patients, medication in the form of pills and complex drug delivery systems is expected to change drastically in the coming years too as these items can be 3D printed quickly, affordably, and in a variety of shapes, sizes, and colors—moving from the conceptual stage to reality with the FDA approval of Aprecia, an epilepsy pill. The trend has continued from there, and although perhaps a bit more slowly than expected, many researchers continue to make strides.

Now, engineers and pharmaceutical scientists from the University of Sussex and the University of Texas at Austin have created a unique method for drug delivery, featuring remote control. 3D-printed pills, in capsule form, are controlled by magnetic fields and triggered for drug delivery to patients as needed. This could mean improved treatment for patients with serious diseases:

“The device delivers enhanced efficacy and safety through optimal drug distribution and absorption in the targeted location at the (sub)cellular level. This device has the potential to be used in treatments for cancer, diabetes, pain, and myocardial infarction which require variable release kinetics where patients’ suffer from discomfort or inconvenience if they currently rely on untunable monotonic drug treatment,” said Professor Ali Nokhodchi, head of Pharmaceutics Research Lab at the University of Sussex School of Life Sciences and corresponding author.

Fabrication of the device reservoir using a standard 3D printing machine.

With the use of magnets, as outlined in “Novel 3D printed device with integrated macroscale magnetic field triggerable anti-cancer drug delivery system,” medication could be directed toward areas requiring drug delivery, and then applied closely.

“The device offers the potential for personalized treatment through the loading of a given drug in a particular concentration and releasing it within different dosage patterns. All results confirmed that the device can provide a safe, long-term, triggerable and reutilizable way for localized disease treatments such as cancer,” said Kejing Shi, doctoral researcher in the University of Sussex’s School of Life Sciences and lead author of the study.

Such targeted delivery could allow patients to forego aggressive treatments like chemotherapy, not only weakening patients but also harming other cells. Errors in dosing could be eliminated also—one of the major reasons for bad side effects.

“Advancing this process further, we could create different compartments in the capsule with different sponges or employ other techniques where the macroporous sponge properties can be tailored to hold two or more substances without being mixed which could deliver more complex courses of treatment,” said Dr. Rodrigo Aviles-Espinosa.

Fabrication of the device reservoir using a standard 3D printing machine.

What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.

[Source / Images: University of Sussex]

Share this Article


Recent News

Will There Be a Desktop Manufacturing Revolution outside of 3D Printing?

Know Your Würth: CEO AJ Strandquist on How Würth Additive Can Change 3D Printing



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Featured

Pressing Refresh: What CEO Brad Kreger and Velo3D Have Learned About Running a 3D Printing Company

To whatever extent a business is successful thanks to specialization, businesses will nonetheless always be holistic entities. A company isn’t a bunch of compartments that all happen to share the...

Würth Additive Launches Digital Inventory Services Platform Driven by 3D Printing

Last week, at the Additive Manufacturing Users’ Group (AMUG) Conference in Chicago (March 10-14), Würth Additive Group (WAG) launched its new inventory management platform, Digital Inventory Services (DIS). WAG is...

Featured

Hypersonic Heats Up: CEO Joe Laurienti on the Success of Ursa Major’s 3D Printed Engine

“It’s only been about 24 hours now, so I’m still digesting it,” Joe Laurienti said. But even via Zoom, it was easy to notice that the CEO was satisfied. The...

Featured

3D Printing’s Next Generation of Leadership: A Conversation with Additive Minds’ Dr. Gregory Hayes

It’s easy to forget sometimes that social media isn’t reality. So, at the end of 2023, when a burst of doom and gloom started to spread across the Western world’s...